\-\ Texto\\:\\ \ \(0\)\
\-\ the\\ patient\\ appeared\\ thin\\ and\\ pale\\,\\ but\\ otherwise\\ well\\.\\ \\ laboratory\\ workup\\ was\\ significant\\ for\\ a\\ hemoglobin\\ of\\ 10\\.2\\ and\\ a\\ hematocrit\\ of\\ 30\\.2\\.\ \(0\)\
\-\ patient\\ is\\ being\\ treated\\ with\\ chemotherapy\\ \\(chop\\)\\.\\ \\ he\\ will\\ have\\ follow\\ up\\ imaging\\ after\\ his\\ third\\ cycle\\ to\\ assess\\ tumor\\ response\\.\ \(0\)\
\-\ ct\\ angiogram\\ was\\ performed\\ demonstrating\\ a\\ large\\ soft\\ tissue\\ mass\\ present\\ within\\ the\\ mesentery\\ measuring\\ 10\\.3\\ by\\ 7\\.3\\ cm\\ in\\ its\\ greatest\\ dimension\\.\\ \\ the\\ mass\\ appears\\ continuous\\ with\\ multiple\\ loops\\ of\\ small\\ bowel\\,\\ several\\ of\\ which\\ demonstrate\\ diffuse\\ wall\\ thickening\\.\\ \\ the\\ mass\\ is\\ seen\\ to\\ encase\\ the\\ superior\\ mesenteric\\ artery\\,\\ which\\ remains\\ patent\\.\\ \\ there\\ is\\ graying\\ of\\ the\\ surrounding\\ mesenteric\\ fat\\,\\ as\\ well\\ as\\,\\ scattered\\ lymph\\ nodes\\.\\ \\ there\\ is\\ central\\ low\\ attenuation\\ of\\ the\\ mass\\,\\ which\\ may\\ represent\\ necrosis\\.\ \(0\)\
\-\ small\\ bowel\\ lymphoma\ \(5\)\
\-\ small\\ bowel\\ adenocarcinoma\ \(1\)\
\-\ metastastic\\ disease\ \(0\)\
\-\ gist\ \(260\)\
\-\ leiomyosarcoma\ \(24\)\
\-\ small\\ bowel\\ lymphoma\ \(5\)\
\-\ patient\\ had\\ a\\ 2\\-month\\ history\\ of\\ increasing\\ intestinal\\/epigastric\\ pain\\ after\\ large\\ meals\\.\\ \\ the\\ patient\\ also\\ reported\\ a\\ twenty\\-pound\\ weight\\ loss\\ in\\ the\\ past\\ 2\\-months\\.\\ \\ the\\ patient\\ denied\\ night\\ sweats\\,\\ fevers\\,\\ melena\\,\\ hematochezia\\ or\\ shortness\\ of\\ breath\\.\\ \\ past\\ medical\\ history\\ is\\ significant\\ for\\ excision\\ of\\ a\\ melanoma\\ from\\ his\\ chin\\ 2\\-years\\ prior\\,\\ as\\ well\\ as\\,\\ a\\ history\\ of\\ hypertension\\,\\ hyperlipidemia\\,\\ and\\ atherosclerotic\\ disease\\.\ \(0\)\
\-\ the\\ most\\ common\\ location\\ for\\ lymphoma\\ of\\ the\\ gastrointestinal\\ tract\\ is\\ in\\ the\\ stomach\\.\\ however\\,\\ the\\ small\\ bowel\\ is\\ the\\ second\\ most\\ common\\ site\\.\\ non\\-hodgkin\\â\\€\\™s\\ lymphoma\\ is\\ the\\ third\\ most\\ common\\ malignancy\\ of\\ the\\ small\\ bowel\\,\\ representing\\ between\\ 10\\-20\\%\\ of\\ all\\ small\\ bowel\\ malignancies\\.\\ \\ because\\ lymphoma\\ is\\ a\\ soft\\,\\ pliable\\ tumor\\,\\ it\\ tends\\ to\\ cause\\ bowel\\ wall\\ thickening\\ and\\ dilatation\\ of\\ the\\ bowel\\ lumen\\ opposed\\ to\\ obstruction\\.\\ \\ in\\ this\\ case\\,\\ the\\ lymphoma\\ was\\ seen\\ to\\ encase\\ the\\ superior\\ mesenteric\\ artery\\ and\\ other\\ mesenteric\\ vessels\\.\\ \\ the\\ images\\ with\\ oral\\ contrast\\ best\\ demonstrate\\ the\\ dilatation\\ of\\ the\\ small\\ bowel\\ loops\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ bowel\\:\\ 0\\.07952384370577921\ \(0\)\
\-\ mesenteric\\:\\ 0\\.046769389920063464\ \(0\)\
\-\ small\\:\\ 0\\.04673175749272685\ \(0\)\
\-\ lymphoma\\:\\ 0\\.04348128132444189\ \(0\)\
\-\ encase\\:\\ 0\\.041684029404975925\ \(0\)\
\-\ 30\\.2\\.\\:\\ 0\\.026158808379722547\ \(0\)\
\-\ intestinal\\/epigastric\\:\\ 0\\.026158808379722547\ \(0\)\
\-\ twenty\\-pound\\:\\ 0\\.026158808379722547\ \(0\)\
\-\ 2\\-months\\:\\ 0\\.026158808379722547\ \(0\)\
\-\ 2\\-years\\:\\ 0\\.026158808379722547\ \(0\)\
\-\ pliable\\:\\ 0\\.026158808379722547\ \(0\)\
\-\ loops\\:\\ 0\\.02486970688832182\ \(0\)\
\-\ metastastic\\:\\ 0\\.024101991820197486\ \(0\)\
\-\ graying\\:\\ 0\\.02204517526067243\ \(0\)\
\-\ 2\\-month\\:\\ 0\\.02204517526067243\ \(0\)\
\-\ dilatation\\:\\ 0\\.021734283854413762\ \(0\)\
\-\ chop\\:\\ 0\\.021383028224131746\ \(0\)\
\-\ 10\\.2\\:\\ 0\\.020384594287570282\ \(0\)\
\-\ third\\:\\ 0\\.020334995217507403\ \(0\)\
\-\ common\\:\\ 0\\.019907423251837364\ \(0\)\
\-\ gist\\:\\ 0\\.019638854144303497\ \(0\)\
\-\ 10\\.3\\:\\ 0\\.019326211664606685\ \(0\)\
\-\ 7\\.3\\:\\ 0\\.019326211664606685\ \(0\)\
\-\ chin\\:\\ 0\\.019326211664606685\ \(0\)\
\-\ 10\\-20\\:\\ 0\\.01904339213996477\ \(0\)\
\-\ melena\\:\\ 0\\.018547682689925703\ \(0\)\
\-\ hematochezia\\:\\ 0\\.01812305110642222\ \(0\)\
\-\ most\\:\\ 0\\.017562330638528866\ \(0\)\
\-\ well\\:\\ 0\\.01720843578310372\ \(0\)\
\-\ thickening\\:\\ 0\\.017190650265242444\ \(0\)\
\-\ meals\\:\\ 0\\.01698657558043971\ \(0\)\
\-\ pale\\:\\ 0\\.016854671240466912\ \(0\)\
\-\ non\\-hodgkin\\:\\ 0\\.016854671240466912\ \(0\)\
\-\ leiomyosarcoma\\:\\ 0\\.01672838158343784\ \(0\)\
\-\ tends\\:\\ 0\\.01672838158343784\ \(0\)\
\-\ cycle\\:\\ 0\\.016607248068540942\ \(0\)\
\-\ opposed\\:\\ 0\\.016378877026593974\ \(0\)\
\-\ superior\\:\\ 0\\.016194324611597574\ \(0\)\
\-\ malignancies\\:\\ 0\\.016166832623086123\ \(0\)\
\-\ past\\:\\ 0\\.016113943453688037\ \(0\)\
\-\ hyperlipidemia\\:\\ 0\\.015694830561870435\ \(0\)\
\-\ mesentery\\:\\ 0\\.015525221025253378\ \(0\)\
\-\ hemoglobin\\:\\ 0\\.015443918431223363\ \(0\)\
\-\ as\\:\\ 0\\.0153421662420668\ \(0\)\
\-\ atherosclerotic\\:\\ 0\\.015212578545556563\ \(0\)\
\-\ artery\\:\\ 0\\.015101068202422546\ \(0\)\
\-\ is\\:\\ 0\\.015016667671995639\ \(0\)\
\-\ hematocrit\\:\\ 0\\.01492975902091465\ \(0\)\
\-\ continuous\\:\\ 0\\.014863073988712698\ \(0\)\
\-\ wall\\:\\ 0\\.01468937163346437\ \(0\)\
\-\ his\\:\\ 0\\.01461655209286013\ \(0\)\
\-\ dimension\\:\\ 0\\.014550431509015882\ \(0\)\
\-\ \\,\\:\\ 0\\.014459291333267574\ \(0\)\
\-\ sweats\\:\\ 0\\.01443404957087558\ \(0\)\
\-\ which\\:\\ 0\\.01420010018316809\ \(0\)\
\-\ mass\\:\\ 0\\.014106362100267828\ \(0\)\
\-\ greatest\\:\\ 0\\.0140094179873721\ \(0\)\
\-\ appeared\\:\\ 0\\.013817909022572183\ \(0\)\
\-\ gastrointestinal\\:\\ 0\\.013817909022572183\ \(0\)\
\-\ significant\\:\\ 0\\.013637075080440495\ \(0\)\
\-\ remains\\:\\ 0\\.013193087749256609\ \(0\)\
\-\ representing\\:\\ 0\\.01308249013858233\ \(0\)\
\-\ workup\\:\\ 0\\.013046521709702968\ \(0\)\
\-\ melanoma\\:\\ 0\\.012941160616359021\ \(0\)\
\-\ patient\\:\\ 0\\.012709079093714956\ \(0\)\
\-\ assess\\:\\ 0\\.012708958251671341\ \(0\)\
\-\ response\\:\\ 0\\.012708958251671341\ \(0\)\
\-\ patent\\:\\ 0\\.012493614949490821\ \(0\)\
\-\ soft\\:\\ 0\\.012349713732899408\ \(0\)\
\-\ denied\\:\\ 0\\.012348837014269956\ \(0\)\
\-\ night\\:\\ 0\\.012320710177609589\ \(0\)\
\-\ angiogram\\:\\ 0\\.012265243907543853\ \(0\)\
\-\ lumen\\:\\ 0\\.012210795424848908\ \(0\)\
\-\ fevers\\:\\ 0\\.012053199504036006\ \(0\)\
\-\ tumor\\:\\ 0\\.011823337101547841\ \(0\)\
\-\ scattered\\:\\ 0\\.011807823492626173\ \(0\)\
\-\ demonstrate\\:\\ 0\\.011670339117703507\ \(0\)\
\-\ nodes\\:\\ 0\\.011453090107908718\ \(0\)\
\-\ tract\\:\\ 0\\.011231692885976446\ \(0\)\
\-\ stomach\\:\\ 0\\.011212361488287446\ \(0\)\
\-\ represent\\:\\ 0\\.011136271189731548\ \(0\)\
\-\ large\\:\\ 0\\.011089272592469316\ \(0\)\
\-\ demonstrating\\:\\ 0\\.011007634866664444\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.010954167491285577\ \(0\)\
\-\ site\\:\\ 0\\.010716652038248377\ \(0\)\
\-\ oral\\:\\ 0\\.010684221561891728\ \(0\)\
\-\ shortness\\:\\ 0\\.010668138275632563\ \(0\)\
\-\ best\\:\\ 0\\.010668138275632563\ \(0\)\
\-\ history\\:\\ 0\\.010506360869795995\ \(0\)\
\-\ after\\:\\ 0\\.01049258873952049\ \(0\)\
\-\ thin\\:\\ 0\\.010421998563523509\ \(0\)\
\-\ excision\\:\\ 0\\.010407272185653689\ \(0\)\
\-\ increasing\\:\\ 0\\.01039261853093386\ \(0\)\
\-\ lymph\\:\\ 0\\.010236030887076104\ \(0\)\
\-\ vessels\\:\\ 0\\.010208427348018793\ \(0\)\
\-\ attenuation\\:\\ 0\\.010194721277228602\ \(0\)\
\-\ measuring\\:\\ 0\\.010140521431598652\ \(0\)\
\-\ seen\\:\\ 0\\.010021528872805283\ \(0\)\
\-\ necrosis\\:\\ 0\\.010009200930102982\ \(0\)\
\-\ hypertension\\:\\ 0\\.009996382944510943\ \(0\)\
\-\ malignancy\\:\\ 0\\.009798485690805686\ \(0\)\
\-\ second\\:\\ 0\\.009739255000709135\ \(0\)\
\-\ its\\:\\ 0\\.009568342562182912\ \(0\)\
\-\ breath\\:\\ 0\\.009481061003707266\ \(0\)\
\-\ appears\\:\\ 0\\.0094383644534043\ \(0\)\
\-\ the\\:\\ 0\\.009435411122205915\ \(0\)\
\-\ a\\:\\ 0\\.009414832090649288\ \(0\)\
\-\ laboratory\\:\\ 0\\.009344485863068446\ \(0\)\
\-\ reported\\:\\ 0\\.009243545550670066\ \(0\)\
\-\ otherwise\\:\\ 0\\.009107760336576691\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.009088859896560431\ \(0\)\
\-\ weight\\:\\ 0\\.009088859896560431\ \(0\)\
\-\ obstruction\\:\\ 0\\.008941839906793578\ \(0\)\
\-\ because\\:\\ 0\\.00887097423319302\ \(0\)\
\-\ location\\:\\ 0\\.008844829931465558\ \(0\)\
\-\ being\\:\\ 0\\.008836166103265753\ \(0\)\
\-\ was\\:\\ 0\\.008797722749676738\ \(0\)\
\-\ cause\\:\\ 0\\.00857941432211266\ \(0\)\
\-\ central\\:\\ 0\\.008343119753293647\ \(0\)\
\-\ surrounding\\:\\ 0\\.0083358019714088\ \(0\)\
\-\ disease\\:\\ 0\\.008289243568045722\ \(0\)\
\-\ several\\:\\ 0\\.008151610788493732\ \(0\)\
\-\ follow\\:\\ 0\\.008056971726844019\ \(0\)\
\-\ between\\:\\ 0\\.008037078742505175\ \(0\)\
\-\ will\\:\\ 0\\.00793317809608054\ \(0\)\
\-\ medical\\:\\ 0\\.007802106231649865\ \(0\)\
\-\ fat\\:\\ 0\\.007711906002616123\ \(0\)\
\-\ diffuse\\:\\ 0\\.007676579882419332\ \(0\)\
\-\ treated\\:\\ 0\\.007590061828142015\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.0075787143609657446\ \(0\)\
\-\ there\\:\\ 0\\.007547273332136431\ \(0\)\
\-\ loss\\:\\ 0\\.007360427811479049\ \(0\)\
\-\ s\\:\\ 0\\.007272307617550704\ \(0\)\
\-\ all\\:\\ 0\\.007171879790597302\ \(0\)\
\-\ he\\:\\ 0\\.007074739887338337\ \(0\)\
\-\ performed\\:\\ 0\\.0070699653745617775\ \(0\)\
\-\ however\\:\\ 0\\.007060439334115936\ \(0\)\
\-\ low\\:\\ 0\\.007050943777051631\ \(0\)\
\-\ up\\:\\ 0\\.006818537540220247\ \(0\)\
\-\ cm\\:\\ 0\\.006801056729427258\ \(0\)\
\-\ prior\\:\\ 0\\.00651072039229188\ \(0\)\
\-\ for\\:\\ 0\\.006490576990884705\ \(0\)\
\-\ to\\:\\ 0\\.006336322083723832\ \(0\)\
\-\ tissue\\:\\ 0\\.006010151894518082\ \(0\)\
\-\ imaging\\:\\ 0\\.005940871882657575\ \(0\)\
\-\ \\%\\:\\ 0\\.005914899208741863\ \(0\)\
\-\ other\\:\\ 0\\.0058446247735977706\ \(0\)\
\-\ present\\:\\ 0\\.00572702894341745\ \(0\)\
\-\ it\\:\\ 0\\.005699846838376904\ \(0\)\
\-\ contrast\\:\\ 0\\.0056758922457207876\ \(0\)\
\-\ may\\:\\ 0\\.005561805248955857\ \(0\)\
\-\ case\\:\\ 0\\.005547490898715937\ \(0\)\
\-\ have\\:\\ 0\\.005490914179124902\ \(0\)\
\-\ had\\:\\ 0\\.005471364448785485\ \(0\)\
\-\ but\\:\\ 0\\.005408021664787946\ \(0\)\
\-\ multiple\\:\\ 0\\.005340670633469641\ \(0\)\
\-\ of\\:\\ 0\\.005185629115637467\ \(0\)\
\-\ in\\:\\ 0\\.005001747538756735\ \(0\)\
\-\ also\\:\\ 0\\.004998871197834277\ \(0\)\
\-\ images\\:\\ 0\\.004864284545843781\ \(0\)\
\-\ within\\:\\ 0\\.004837185188089263\ \(0\)\
\-\ by\\:\\ 0\\.0042221688523586785\ \(0\)\
\-\ from\\:\\ 0\\.0037579694752350517\ \(0\)\
\-\ ct\\:\\ 0\\.003546895113922976\ \(0\)\
\-\ pain\\:\\ 0\\.003096760141040756\ \(0\)\
\-\ or\\:\\ 0\\.0029718775933641173\ \(0\)\
\-\ this\\:\\ 0\\.0028520392086472794\ \(0\)\
\-\ and\\:\\ 0\\.002670756761605615\ \(0\)\
\-\ \\(\\:\\ 0\\.0021435066060648683\ \(0\)\
\-\ \\)\\:\\ 0\\.002117322528526128\ \(0\)\
\-\ \\.\\:\\ 0\\.0018961176550511363\ \(0\)\
\-\ with\\:\\ 0\\.0010415802025806207\ \(0\)\
